IL-13 and its Signal Pathway: Promising Targets in the Development of a Therapeutic Agent for Bronchial Asthma

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|2|1|31-40

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.2, Iss.1, 2007-01, pp. : 31-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signal Transduction Pathway Regulated by Genistein and its Therapeutic Use

By  

Current Signal Transduction Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 231-233

Bentham Science Publishers

Access to resources Recommend Favorite

CD4+IL13+ T Lymphocytes at Birth and the Development of Wheezing and/or Asthma during the 1st Year of Life

By  

International Archives of Allergy and Immunology, Vol. 124, Iss. 4, 2001-04 ,pp. : 497-501

Karger

Access to resources Recommend Favorite

5‐/12‐Lipoxygenase‐linked cascade contributes to the IL‐33‐induced synthesis of IL‐13 in mast cells, thus promoting asthma development

By  

ALLERGY, Vol. 73, Iss. 2, 2018-02 ,pp. : 350-360

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression and Effects of IL-33 and ST2 in Allergic Bronchial Asthma: IL-33 Induces Eotaxin Production in Lung Fibroblasts

By  

International Archives of Allergy and Immunology, Vol. 155, Iss. 1, 2011-06 ,pp. : 12-20

Karger

Access to resources Recommend Favorite

IL-13Rα2 Reverses the Effects of IL-13 and IL-4 on Bronchial Reactivity and Acetylcholine-Induced Ca2+ Signaling

By  

International Archives of Allergy and Immunology, Vol. 142, Iss. 3, 2006-11 ,pp. : 199-210

Karger

Access to resources Recommend Favorite